Logo

Axys and Signal Enter Discovery Collaboration

Dec 18, 1998
Premium

SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals and Signal Pharmaceuticals announced they have entered into a collaboration for the accelerated discovery of compounds that interact with specific cell signaling pathways. Signal will use its proprietary assays to screen small molecules derived from Axys's compound libraries. Specific molecular targets were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.